Vor Biopharma Inc.

NASDAQ: VOR
Share price (8/15/25): $2.14
Market cap (8/15/25): $271 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 03/31/24 Q1 2024 – amended

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Prospectus supplement

Shelf registration

Registration of securities for employees

Ownership Filter

Lundberg Sven Ante

News Filter

Bio Appoints Qing Zuraw, M.D. as Chief Development Officer

Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer

Bio Enters Into Exclusive Global License Agreement With RemeGen for Late-Stage Autoimmune Asset

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Change in Directors, Officers or Compensation

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness